UPB Latest Press Releases

-- November 25, 2025 --

Upstream Bio to Participate in Upcoming December Investor Conferences Globe Newswire 7:00 AM

-- November 5, 2025 --

Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Globe Newswire 7:00 AM

-- October 31, 2025 --

Upstream Bio to Participate in Upcoming November Investor Conferences Globe Newswire 7:00 AM

-- September 30, 2025 --

Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug's Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress Globe Newswire 4:15 AM

-- September 9, 2025 --

Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum Globe Newswire 7:00 AM

-- September 2, 2025 --

Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Globe Newswire 6:00 AM

-- September 1, 2025 --

Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Globe Newswire 5:00 PM

-- August 6, 2025 --

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress Globe Newswire 7:00 AM

-- July 21, 2025 --

Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software